100% tevredenheidsgarantie Direct beschikbaar na je betaling Lees online óf als PDF Geen vaste maandelijkse kosten 4,6 TrustPilot
logo-home
Tentamen (uitwerkingen)

MSN571 Advanced Pharmacology - Final Exam Review(Qns & Ans)

Beoordeling
-
Verkocht
1
Pagina's
33
Cijfer
A+
Geüpload op
27-06-2025
Geschreven in
2024/2025

MSN571 Advanced Pharmacology - Final Exam Review(Qns & Ans) MSN571 Advanced Pharmacology - Final Exam Review(Qns & Ans)












Oeps! We kunnen je document nu niet laden. Probeer het nog eens of neem contact op met support.

Documentinformatie

Geüpload op
27 juni 2025
Aantal pagina's
33
Geschreven in
2024/2025
Type
Tentamen (uitwerkingen)
Bevat
Vragen en antwoorden

Onderwerpen

Voorbeeld van de inhoud

MSN571

Advanced Pharmacology

Final Exam Review

(Questions & Solutions)

2025




1

, Question 1
Case Scenario: A 7‑day‑old preterm neonate with suspected sepsis is
prescribed gentamicin. Given the neonate’s physiology, which
pharmacokinetic factor most increases the risk of toxicity in this age
group?
- A) Increased gastrointestinal motility
- B) Reduced glomerular filtration rate
- C) Enhanced protein binding
- D) Faster hepatic metabolism

Correct ANS: B
Rationale: Neonates have immature renal function, including a reduced
glomerular filtration rate, which decreases gentamicin clearance and
heightens the risk of toxicity.

---

Question 2
Case Scenario: A 4‑year‑old child is started on valproic acid for seizure
control. Compared with adults, pediatric patients often require dosing
adjustments.
Question: Which pharmacokinetic property in children generally
necessitates a higher mg/kg dosing of medications like valproic acid?
- A) Decreased metabolic clearance
- B) Lower distribution volume
- C) Increased hepatic enzyme activity relative to body weight
- D) Reduced renal excretion

Correct ANS: C
Rationale: Children often have a relatively higher metabolic rate and
increased hepatic enzyme activity per kilogram body weight, leading to
faster clearance of drugs and the need for proportionally higher dose-
per-weight regimens.
2

,---

Question 3
Case Scenario: A 30‑year‑old pregnant woman with epilepsy maintained
on lamotrigine experiences a breakthrough seizure during her second
trimester.
Question: Which pharmacokinetic change during pregnancy is most
likely responsible for the reduced plasma concentration of lamotrigine?
- A) Decreased renal clearance
- B) Increased plasma protein binding
- C) Upregulated hepatic metabolism (enzyme induction)
- D) Reduced gastrointestinal absorption

Correct ANS: C
Rationale: During pregnancy, estrogen‐mediated enzyme induction
upregulates hepatic metabolism, increasing lamotrigine clearance and
thereby lowering its plasma concentration, which may lead to
breakthrough seizures.

---

Question 4
Case Scenario: A 75‑year‑old female with insomnia is prescribed a
low‑dose, long‑acting benzodiazepine.
Question: Which age‑related physiological change most contributes to
prolonged drug half‑life in this patient?
- A) Reduced cardiac output
- B) Increased adipose tissue
- C) Increased plasma volume
- D) Enhanced first‑pass metabolism

Correct ANS: B
Rationale: With aging, an increased proportion of adipose tissue
provides a larger reservoir for lipophilic drugs (e.g., benzodiazepines),
3

, prolonging their half‑life and increasing the risk of accumulation and
adverse effects.

---

Question 5
Case Scenario: A 68‑year‑old man with chronic kidney disease is
prescribed a renally excreted antibiotic for pneumonia.
Question: Which principle should guide his medication management?
- A) Initiate drug therapy at standard doses regardless of renal function
- B) Adjust the dosage based on renal clearance measurements
- C) Use only parenteral routes to bypass hepatic metabolism
- D) Increase the dosing frequency to maintain therapeutic levels

Correct ANS: B
Rationale: In patients with reduced renal function, dose adjustments
based on measured renal clearance help avoid drug accumulation and
toxicity.

---

Question 6
Case Scenario: A 5‑year‑old child is being evaluated for an acute
infection. Compared to adults, pediatric patients demonstrate
differences in drug metabolism.
Question: Which statement best explains pediatric differences in drug
metabolism?
- A) Neonates and older children have uniformly reduced CYP enzyme
activity
- B) Infants generally have slower metabolism, but by age five,
increased liver size relative to body weight enhances drug clearance
- C) Pediatric patients eliminate drugs solely through renal pathways
- D) All drugs require the same dosing regimen across childhood and
adulthood


4

Maak kennis met de verkoper

Seller avatar
De reputatie van een verkoper is gebaseerd op het aantal documenten dat iemand tegen betaling verkocht heeft en de beoordelingen die voor die items ontvangen zijn. Er zijn drie niveau’s te onderscheiden: brons, zilver en goud. Hoe beter de reputatie, hoe meer de kwaliteit van zijn of haar werk te vertrouwen is.
Bankart Chamberlain College of Nursing
Bekijk profiel
Volgen Je moet ingelogd zijn om studenten of vakken te kunnen volgen
Verkocht
150
Lid sinds
2 jaar
Aantal volgers
31
Documenten
4512
Laatst verkocht
1 week geleden

3.6

21 beoordelingen

5
9
4
0
3
9
2
1
1
2

Recent door jou bekeken

Waarom studenten kiezen voor Stuvia

Gemaakt door medestudenten, geverifieerd door reviews

Kwaliteit die je kunt vertrouwen: geschreven door studenten die slaagden en beoordeeld door anderen die dit document gebruikten.

Niet tevreden? Kies een ander document

Geen zorgen! Je kunt voor hetzelfde geld direct een ander document kiezen dat beter past bij wat je zoekt.

Betaal zoals je wilt, start meteen met leren

Geen abonnement, geen verplichtingen. Betaal zoals je gewend bent via iDeal of creditcard en download je PDF-document meteen.

Student with book image

“Gekocht, gedownload en geslaagd. Zo makkelijk kan het dus zijn.”

Alisha Student

Veelgestelde vragen